🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Chengdu
Clinical trial register · China

Clinical Trials in Chengdu

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Chengdu 162 Sichuan 5 Xiamen 3 Beijing 3 Chongqing 3
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
West China Hospital162 AstraZeneca148 Janssen Research & Development, LLC55 Hoffmann-La Roche44 Sichuan University44 Clear sponsor filter
Site location
Chengdu162 Sichuan5 Xiamen3 Beijing3 Chongqing3
All 22 locations
Target enrolment
to
162 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Phase I Study of the Safety, Tolerability, and Efficacy of an Engineered Mitochondrial Vaccine in Advanced Solid Tumors
NCT06927297Advanced Solid Tumor Malignancies, Advanced Solid Malignancies
West China Hospital
Phase 1
12
Chengdu
2025-05-09
Not yet open
Regret Emotion After Thyroidectomy in Low-Risk Papillary Thyroid Cancer
NCT06804863Thyroid Cancer, Regret
West China Hospital
Not applicable
600
Chengdu
2025-05-01
Recruiting
A Study of GnP RegimenCombined With Serplulimab and Stereotactic Body Radiation Therapy as First-line Treatment for Locally Advanced Pancreatic Cancer
NCT07101679Locally Advanced Pancreatic Ductal Adenocarcinoma
West China Hospital
Phase 2
23
Chengdu
2025-04-16
Recruiting
Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma
NCT06950827Hepatocellular Carcinoma, Hepatectomy, Laparoscopic Hepatectomy
West China Hospital
Observational
400
Chengdu
2025-04-05
Recruiting
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
NCT06950814Sarcomatoid Carcinoma, Liver Cancer, Adjuvant Therapy
West China Hospital
Observational
50
Chengdu
2025-04-05
Recruiting
Clinical Characteristics and Epidemiology of Chronic Critically Ill Patients in China
NCT07372742Chronic Critically Ill
West China Hospital
Observational
459
Chengdu
2025-03-29
Recruiting
Phase II Study of PD-1 Inhibitor Combined With Apatinib and Mitotane in the Treatment of Advanced Adrenal Cortical Carcinoma
NCT06831175Adrenal Cortical Carcinoma, Adrenal Cortical Cancer, Adrenal Cancer
West China Hospital
Phase 2
28
Chengdu
2025-03-15
Recruiting
Hepatic Arterial Infusion Chemotherapy (HAIC) Combined With Durvalumab and Lenvatinib in Patients With Locally Advanced or Metastatic Intrahepatic Cholangiocarcinoma: a Phase 2 Study(HAIC-quad Trial)
NCT06859684Intrahepatic Cholangiocarcinoma (Icc), HAIC, Durvalumab
West China Hospital
Phase 2
25
Chengdu
2025-03-01
Active, closed
Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer
NCT06865521Colo-rectal Cancer, PD-1 Inhibitor, Akkermansia Muciniphila
West China Hospital
Not applicable
22
Chengdu
2025-02-21
Active, closed
HRS-4642 Combined With Nimotuzumab in the Treatment of Recurrent or Metastatic Pancreatic Ductal Adenocarcinoma
NCT06773130Pancreatic Ductal Adenocarcinoma (PDAC)
West China Hospital
Phase 1/2
20
Chengdu
2025-02-10
Not yet open
Fascia Iliaca Compartment Block and Tramadol for Analgesia in Hip Fracture
NCT06728033Hip Fractures, Ultrasound-guided Nerve Block, Perioperative Analgesia
West China Hospital
Not applicable
240
Chengdu
2025-01-01
Not yet open
Low-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children
NCT06763315Plexiform Neurofibromas (PN)
West China Hospital
Phase 2
50
Chengdu
2025-01-01
Recruiting
Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of Ulcerated Infantile Hemangioma
NCT06798363Infantile Hemangioma
West China Hospital
Phase 2/3
32
Chengdu
2025-01-01
Not yet open
Erector Spinae Plane Block v.s Patient Controlled Analgesia in Correction Surgery for Idiopathic Scoliosis
NCT06728046Idiopathic Scoliosis, Erector Spinae Plane Block, Patient Controlled Analgesia
West China Hospital
Not applicable
40
Chengdu
2025-01-01
Recruiting
XELOX Combined With Sintilimab and HBO for Advanced or Metastatic GC/GEJC
NCT06742411Gastric (Stomach) Cancer
West China Hospital
Phase 1/2
57
Chengdu
2024-12-31
Recruiting
A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV Virus
NCT06741982HNSCC, Lysogenic HSV Virus, Neoadjuvant Therapy, Immunotherapy
West China Hospital
Phase 1
21
Chengdu
2024-12-15
Not yet open
Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer
NCT06713057Locally Advanced Thyroid Gland Carcinoma, Thyroid Cancer
West China Hospital
Phase 2
20
Chengdu
2024-12-01
Recruiting
Different Doses of Sirolimus for the Treatment of Cystic Lymphatic Malformations
NCT06673290Lymphatic Malformation
West China Hospital
Phase 2/3
150
Chengdu
2024-11-30
Recruiting
Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study
NCT07020247Locally Advanced Rectal Cancer (LARC), Immunotherapy, Radiotherapy, Total Neoadjuvant Therapy
West China Hospital
Phase 3
184
Chengdu
2024-11-19
Recruiting
Predicting Tumor Origin Based on Deep Learning of Lymph Node Puncture Cytology
NCT06810349Lymph Nodes With Tumor Metastasis
West China Hospital
Observational
10,000
Chengdu
2024-11-11
Not yet open
Placebo Response of Different Types of Sham Acupuncture for Knee Osteoarthritis
NCT06675981Knee Osteoarthritis
West China Hospital
Not applicable
150
Nanchang, Chengdu
2024-11-10
Recruiting
A Randomized Controlled Trial of a Web-based Platform for Cancer Pain Management
NCT06663956Cancer Pain
West China Hospital
Phase 3
100
Chengdu
2024-11-10
Recruiting
Planed Organ Preservation for Low Rectal Cancer After Neoadjuvant Chemotherapy (OPLAR)
NCT07070622Rectal Cancer
West China Hospital
Phase 3
186
Chengdu
2024-11-01
Active, closed
Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinomas
NCT06654297Esophageal Squamous Cell Carcinoma
West China Hospital
Phase 1
6
Chengdu
2024-10-27
Recruiting
Sintilimab Combined SBRT As Neoadjuvant Therapy for Resectable HCC with PVTT
NCT06664996Hepatocellular Carcinoma (HCC)
West China Hospital
Phase 2
33
Chengdu
2024-10-15
Active, closed
CAPOX Plus Sintilimab and Bevacizumab Biosimilar (IBI305) for Neoadjuvant Treatment of Locally Advanced Gastric Cancer
NCT06667050Gastric Adenocarcinoma
West China Hospital
Phase 2
58
Chengdu
2024-10-10
Recruiting
PD-L1 Antibody + Bevacizumab With Hepatic Arterial Infusion Chemotherapy for Advanced HCC
NCT06742424Hepato Cellular Carcinoma (HCC)
West China Hospital
Phase 2
36
Chengdu
2024-10-01
Not yet open
Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases
NCT06666153CAEBV (Chronic Active Epstein-Barr Virus Infection) Syndrome, PTLDs
West China Hospital
Phase 1
27
Chengdu
2024-10
Recruiting
AI App for Management of Atopic Dermatitis
NCT06362629Atopic Dermatitis, Artificial Intelligence
West China Hospital
Not applicable
232
Chengdu
2024-09-01
Recruiting
Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma
NCT06438822Cholangiocarcinoma
West China Hospital
Phase 2
51
Chengdu
2024-08-30
Recruiting
A Study of Online Follow-up in Patients With Papillary Thyroid Cancer
NCT06800482Thyroid, Papillary Thyroid Cancer
West China Hospital
Not applicable
388
Chengdu
2024-08-07
Recruiting
Identifying Local Field Potential Biomarkers for Obsessive-compulsive Disorder Treatment With Deep Brain Stimulation
NCT06542224Obsessive-Compulsive Disorder
West China Hospital
Not applicable
16
Chengdu, Zigong
2024-08-03
Recruiting
Identifying Local Field Potential Biomarkers for Treatment-Resistant Major Depression With Deep Brain Stimulation
NCT06542094Major Depressive Disorder, Treatment Resistant Depression
West China Hospital
Not applicable
12
Chengdu
2024-08-03
Active, closed
AK117 (Anti-CD47 mAb) Plus Cetuximab or AK104 (Anti-PD-1/CTLA-4 bsAb) as Second-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
NCT06508606Head and Neck Squamous Cell Carcinoma
West China Hospital
Phase 2
20
Chengdu
2024-08-01
Recruiting
A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of JWK008 in Patients With Mucopolysaccharidosis Type I
NCT06519552Mucopolysaccharidosis Type I
West China Hospital
Phase 1
6
Chengdu
2024-07-22
Recruiting
Individualized ANH for Non-cardiac Surgery
NCT06399536Transfusion Related Complication, Hemodilution
West China Hospital
Not applicable
40
Chengdu
2024-06-01
Active, closed
Maternal Use of Antibiotics and the Risk of Congenital Malformations
NCT06770465Congenital Malformations
West China Hospital
Observational
850,000
Chengdu
2024-06-01
Recruiting
Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
NCT06341270Liver Cancer
West China Hospital
Not applicable
524
Chengdu
2024-05-06
Recruiting
Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy
NCT06406244Liver Cancer
West China Hospital
Not applicable
524
Chengdu
2024-04-20
Recruiting
CtDNA in Adjuvant Chemotherapy of Stage III Colon Cancer (REVISE Trial)
NCT06242418Colon Cancer
West China Hospital
Phase 2
60
Guiyang, Chengde, Chengdu, Kunming
2024-03-25
Active, closed
A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD)
NCT06114056Duchenne Muscular Dystrophy
West China Hospital
Phase 1
3
Chengdu
2024-01-31
Not yet open
Study of Adaptive Radiotherapy for High-grade Glioma Based on Interfraction MRI
NCT06201351High-grade Glioma
West China Hospital
Observational
60
Chengdu
2024-01-01
Not yet open
Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis
NCT06122753Portal Hypertension, Portal Vein Thrombosis, Esophageal Varix Bleeding, Portosystemic Shunt
West China Hospital
Not applicable
120
Chengdu
2024-01
Recruiting
Application of ICG@HSA Complexes in Fluorescence Image-Guided Laparoscopic Anatomical Liver Resection
NCT06219096Malignant Tumor of Liver, Randomized Controlled Trial
West China Hospital
Not applicable
100
Chengdu
2023-12-10
Recruiting
Immune Checkpoint Inhibitors Intrathecal Injection in Patients With Leptomeningeal Metastases in NSCLC
NCT06132698NSCLC Associated With Leptomeningeal Metastases
West China Hospital
Phase 2
17
Chengdu
2023-11-30
Active, closed
Safety and Efficacy of a Single Subretinal Injection of JWK006 Gene Therapy in Subjects With Stargardt Disease(STGD1)
NCT06300476Stargardt Disease 1
West China Hospital
Phase 1/2
9
Chengdu
2023-11-20
Recruiting
Safety and Efficacy of a Single Subretinal Injection of JWK002 Gene Therapy in Subjects With X-linked Retinoschisis(XLRS)
NCT06345898X Linked Retinoschisis
West China Hospital
Phase EARLY_PHASE1
12
Chengdu
2023-11-17
Recruiting
Assessment System of Sarcopenia in Lung Cancer Patients
NCT06327594Sarcopenia, Lung Cancer, Ultrasound
West China Hospital
Observational
1,500
Chengdu
2023-11-01
Recruiting
Physiological Studies in the Prone Position in Patients With ARDS
NCT06586736Acute Respiratory Distress Syndrome, Mechanical Ventilation, Prone Positioning
West China Hospital
Observational
100
Chengdu
2023-09-01
Recruiting
Effect of Esketamine and Lidocaine on Postoperative Chronic Pain and Long-term Survival in Patients Undergoing Hepatectomy
NCT06778460Postoperative Chronic Pain
West China Hospital
Not applicable
304
Chengdu
2023-05-05
Recruiting
Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer
NCT05640609Stomach Neoplasm
West China Hospital
Phase 1/2
57
Chengdu
2023-03-10
Recruiting
Use of Bleomycin in the Sclerotherapy of Lymphatic Malformations for Pediatric Patients
NCT06437158Lymphatic Malformation
West China Hospital
Phase 2
200
Chengdu
2023-03-08
Active, closed
Clinical Study of Therapeutic Immunological Agent for EBV-positive Advanced Malignant Tumors
NCT05707910Malignant Tumor
West China Hospital
Phase 1
6
Chengdu
2023-02-08
Active, closed
Application of mRNA Immunotherapy Technology in Epstein-Barr Virus-related Refractory Malignant Tumors
NCT05714748Malignant Tumors
West China Hospital
Phase 1
19
Chengdu
2023-02-08
Recruiting
Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
NCT05447702Triple Negative Breast Cancer
West China Hospital
Phase 2
35
Chengdu
2022-11-01
Active, closed
Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for Low/Intermediate Risk II/III Rectal Cancer
NCT04922853Rectal Cancer, Neoadjuvant Chemotherapy
West China Hospital
Phase 3
554
Wuxi, Chengdu, Kunming
2021-08-26
Recruiting
Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer
NCT06482086Locally Advanced Thyroid Gland Carcinoma
West China Hospital
Phase 2
75
Chengdu
2021-06-01
Recruiting
The Application of Artificial Intelligence in Wrist and Hand Joint Ultrasound
NCT06883669Education, Joint Diseases
West China Hospital
Observational
500
Chengdu
2021-01-01
Recruiting
Assessment System for Sarcopenia Based on Ultrasonographic Data
NCT06199856Sarcopenia, Ultrasound
West China Hospital
Observational
1,500
Chengdu
2020-10-01
Recruiting
The Impact of Sepsis on Long-term Outcomes in Critical Ill Children With Sepsis
NCT06323226Sepsis, Children, Only
West China Hospital
Observational
300
Chengdu
2019-01-01
By invitation
Oxycodone and Sufentanil for Analgesia in Hip Surgery
NCT03685188Analgesia, Patient-Controlled
West China Hospital
Phase 4
570
Chengdu
2018-12-01
Recruiting
Radiotherapy Versus Radiotherapy Combined With Temozolomide in High-risk Low-grade Gliomas After Surgery
NCT04316039Low-grade Glioma
West China Hospital
Phase 2/3
250
Chengdu
2018-04-10
Rows per page Showing 101–162 of 162
Previous 1 2
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china/city/chengdu?page=2

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.